Mutations of resistance of HIV-1 in previously untreated patients of penitentiary centers of the autonomous community of Valencia, Spain. REPRICOVA study

Medicina Clinica

Volumn 118, Issue 7, 2002, Pages 247-250

  García Guerrero, Julio ^a   Herrero, Agustín ^a   Vera, Enrique ^a   Almenara, José M ^b   Araújo, Rosa ^b   Saurí, Vicente ^b   Castellano, Juan C ^c   Fernández Clemente, Luis ^c   Bedia, Miguel ^d   Llorente, María I ^d   González Morén, Francisco ^e  

^a Centro Penitenciario de Castellon   (Spain)

^b Centro Penitenciario de Valencia Cumplimiento   (Spain)

^c Centro Penitenciario de Valencia Preventivos   (Spain)

^d Centro Penitenciario de Alicante Cumplimiento   (Spain)

^e Centro de Salua Pública   (Spain)

Author keywords

HIV; Mutations of resistance; Prison

Indexed keywords

PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ABACAVIR; ANTIRETROVIRUS AGENT; INDINAVIR; PROTEINASE; TRANSCRIPTASE; ZIDOVUDINE;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE; MUTATION; PRISONER; CLINICAL FEATURE; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; GENE AMPLIFICATION; GENE SEQUENCE; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MULTICENTER STUDY; PLASMA; POLYMERASE CHAIN REACTION; PREVALENCE; PRISON; RANDOMIZATION; SAMPLING; SPAIN; VIRUS GENE; VIRUS MUTATION; VIRUS RESISTANCE; VIRUS STRAIN; VIRUS TRANSCRIPTION;

ADULT; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MULTIPLE, VIRAL; FEMALE; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MALE; MIDDLE AGED; MUTATION; PRISONERS; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 0037006515     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(02)72350-6     Document Type: Article

References (29)

1. Public health implications of antiretroviral therapy and HIV drug resistance
2. Transmission of zidovudine resistant HIV-1
3. Primary infection with zidovudine-resistant human inmunodeficency virus type 1
4. Transmission of zidovudine resistant HIV-1 trough heterosexual contacts
5. Primary infection with zidovudine-resistant HIV
6. Differential Characteristics of AIDS Patients with a History of Imprisonment
7. Epidemiology of AIDS incarcerated persons in the United States, 1994-1996
8. Estudio multicéntrico de incidencia de infección por VIH en reclusos de Barcelona. Evidencia de seroconversión en el medio penitenciario
9. Transmission in a prison system in a Australian state
10. Correlation between HIV and HCV in Brazilian prisoners: Evidence for parenteral transmission inside prison
11. HIV Drug Resistance in the Texas Departament of Criminal Justice
12. Therapeutics ethics and communities at risk in the presence of potential mutation to resistant strains to HIV antiviral medications
13. Antiretroviral drug resistance testing in adults with HIV infection. Implications for clinical management
14. Mutations associated to resistance to NRTI and PI in HIV-1 viral genotype in naïve patients in a Spanish prison
15. Mutaciones de resistencia en el VIH-1 de internos naive de las prisiones de la Comunidad Valenciana
16. Sida y población reclusa en España
17. Documento de consenso de GESIDA sobre la utilización de los estudios de resistencia en la práctica clínica
18. Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy
19. Overview of prevalence of HIV drug resistance in antiretroviral inexperienced patients in Europe
20. Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-1 infected patients in Spain
21. Prevalence of genotipyc resistance to nucleoside analogues and protease inhibitors in Spain
22. Primary genotype resistance in HIV naive patients in Valencian Community (Spain): The Recova Study
23. y Grupo Andaluz para el estudio de las Enfermedades Infecciosas. Prevalencia de mutaciones primarias en el virus de la inmunodeficiencia humana que confieren resistencia a análogos de nucleósidos en tratados previamente
24. Line probe assay (LiPA) for rapid detection of drug-selected mutations in the HIV type 1 reverse transcriptase gene
25. Worldwide Evaluation of DNA Sequencing Approaches for Identification of Drug Resistance Mutations in the Human Inmunodeficency Virus Type 1 Reverse Transcriptase
26. Changes in the rate of genotypic resistance to antiretroviral drugs in Spain
27. La resistencia a los fármacos antirretrovirales en pacientes no tratados es baja en España
28. Primary HIV-1 resistance in Spain before and after the introduction of protease inhibitors